Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 24.92
+0.42 (1.71%)
Aug 4, 2026, 3:04 PM CST
Hubei Goto Biopharm Group Market Cap
Hubei Goto Biopharm Group has a market cap or net worth of 2.85 billion as of August 4, 2026. Its market cap has decreased by -7.46% in one year.
Market Cap
2.85B
Enterprise Value
4.17B
Revenue
628.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.92
ChartMarket Cap Chart
Since April 9, 2021, Hubei Goto Biopharm Group's market cap has decreased from 6.57B to 2.85B, a decrease of -56.68%. That is a compound annual growth rate of -14.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.85B | 25.60% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Serum Bio-Technology | 3.12B |
| Baolingbao Biology | 3.05B |
| Zhejiang Shouxiangu Pharmaceutical | 2.94B |
| Qingdao Vland Biotech INC. | 2.92B |
| Guanhao Biotech | 2.87B |
| Guangdong VTR Bio-Tech | 2.80B |
| Beijing Kawin Technology Share-Holding | 2.66B |
| Yantai Zhenghai Biotechnology | 2.54B |